14 July 2022
Allen & Overy advises Bayer on the sale of Nebido™ to Grünenthal Share on Facebook Share on Twitter Share on LinkedIn Share on Xing Share on WeChat Print
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Dr Nicolaus Ascherfeld Lead | A&O Shearman | Partner | Corporate/M&A | Hamburg |
| Dr Sebastian Remberg Lead | A&O Shearman | Counsel | Corporate/M&A | Not stated |
| Dr Markulf Behrendt | A&O Shearman | Partner | Employment | Hamburg |
| Dr Udo H Olgemöller | A&O Shearman | Partner | Public Law | Frankfurt |
| Dr Jens Matthes | A&O Shearman | Partner | IP | Düsseldorf |
| Marie-Luise von Buchwaldt | A&O Shearman | Counsel | Corporate/M&A | Hamburg |
| Anna Kräling | A&O Shearman | Senior associate | IP/IT | Düsseldorf |
| Stefanie Günther | A&O Shearman | Senior associate | Public Law | Frankfurt |
| Louisa Graubner | A&O Shearman | Associate | Corporate/M&A | Hamburg |
| Kornelius Lotha | A&O Shearman | Associate | Corporate/M&A | Hamburg |
| Merle Herrmann | A&O Shearman | Associate | Employment | Hamburg |
| Dario Barbato | A&O Shearman | Other | Corporate/M&A | Hamburg |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 500m (up to EUR 500 million)
- What the figure measures
- Total transaction value
- Client
- Bayer AGSell-side
- Counterparties
- Grünenthal (Buy-side)